Ambroxol as a Novel Disease Modifying Treatment for Lewy Body Dementia

Clinical trial NCT04405596 · NOT_YET_RECRUITING

Trial details

NCT number: NCT04405596
Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Lewy Body Disease

Start date: 2025-01-01
Primary completion: 2026-01-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.